EC16 Nanoformulation: A Potential Nasal Drug for Treating Long COVID
OBJECTIVES: To test the effectiveness of EGCG palmitate (EC16), a lipophilic derivative of (-)-epigallocatechin-3-gallate (EGCG, an anti-oxidant catechin component found in green tea), in reducing the neurological complications of persistent SARS CoV-2 infection particularly in the Human Olfactory E...
Saved in:
Main Authors: | Garrison Lovett (Author), Stephen Hsu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment
by: Nicolette Frank, et al.
Published: (2024) -
Potential of nanoformulations in malaria treatment
by: Janaina Braga Chaves, et al.
Published: (2022) -
Curcumin Nanoformulation for Pulmonary Drug Delivery
by: Sandy Vitria Kurniawan, et al.
Published: (2022) -
The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
by: An T, et al.
Published: (2022) -
Immunomodulatory and anti-inflammatory therapeutic potential of gingerols and their nanoformulations
by: Çiğdem Yücel, et al.
Published: (2022)